Cargando…
The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects
Despite efforts to increase folic acid (FA) intake, even within countries mandating FA fortification, there remain pregnant women with folate levels inadequate to minimize congenital disorders (e.g., of the neural tube, heart, and lip/palate). The pharmacokinetics of FA and [6S]-5-methyltetrahydrofo...
Autores principales: | Bailey, Steven W., Ayling, June E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840174/ https://www.ncbi.nlm.nih.gov/pubmed/29511242 http://dx.doi.org/10.1038/s41598-018-22191-2 |
Ejemplares similares
-
Reversal of Methotrexate Toxicity in Mice by 5-Methyltetrahydrofolic Acid
por: Blair, J. A., et al.
Publicado: (1970) -
Metabolism of 5-methyltetrahydrofolate by rats bearing the Walker 256 carcinosarcoma.
por: Kennelly, J. C., et al.
Publicado: (1982) -
Folate Insufficiency Due to MTHFR Deficiency Is Bypassed by 5-Methyltetrahydrofolate
por: Vidmar Golja, Maša, et al.
Publicado: (2020) -
Biosynthesis of L‐5‐methyltetrahydrofolate by genetically engineered Escherichia coli
por: Wang, Yubo, et al.
Publicado: (2022) -
Pharmacokinetics of Sodium and Calcium Salts of (6S)-5-Methyltetrahydrofolic Acid Compared to Folic Acid and Indirect Comparison of the Two Salts
por: Obeid, Rima, et al.
Publicado: (2020)